1. GSK aims to make 1B doses of vaccine booster for multiple COVID-19 partners — Protalix and Chiesi get close to potential Fabry disease treatment approval — AstraZeneca locks up COVID-19 vaccine supply with Oxford BioMedica deal — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

National Sales Meeting

Discussion in 'Becton Dickinson' started by anonymous, Nov 6, 2018 at 10:45 AM.

  1. anonymous

    anonymous Guest

    So this will be the first official sales meeting after Bard has been "officially" folded into the giant that is BD.

    What are your expectations? How do you feel about things...? Ivan Tornos is gone.

    When you reply, it'd be great if you could mention what division of Bard you work in. I'm super curious about the Endourology division, in particular. We've lost another rep. NCAL is gone. That leaves only 16 reps left - and only 3 in the West.

    Someone cue the theme from Titanic - 'cause this ship is sinking...
     
  2. anonymous

    anonymous Guest

    So far, not enough coffee to keep me awake - borefest to the max!

    Need more hot chicks in here, too.
     
  3. anonymous

    anonymous Guest

    Heard rumors about how much they spent at the meeting. Can anyone confirm whether a number was disclosed? Seems over the top if the number I heard was true.